Virpax Pharmaceuticals Inc (NASDAQ:VRPX) price on Thursday, March 20, fall -8.35% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.10.
A look at the stock’s price movement, the close in the last trading session was $0.11, moving within a range at $0.0956 and $0.1028. The beta value (5-Year monthly) was 0.964. Turning to its 52-week performance, $4.82 and $0.10 were the 52-week high and 52-week low respectively. Overall, VRPX moved -63.99% over the past month.
Virpax Pharmaceuticals Inc’s market cap currently stands at around $2.65 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-02.
Turning to the stock’s technical picture we see that short term indicators suggest on average that VRPX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
VRPX’s current price about -47.91% and -61.74% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 19.29, while 7-day volatility ratio is 12.39% and 9.95% in the 30-day chart. Further, Virpax Pharmaceuticals Inc (VRPX) has a beta value of 1.22, and an average true range (ATR) of 0.03. Analysts have given the company’s stock an average 52-week price target of $3, forecast between a low of $3 and high of $3. Looking at the price targets, the low is -2900.0% off current price level while to achieve the yearly target high, price needs to move -2900.0%. Nonetheless, investors will most likely welcome a -2900.0% jump to $3 which is the analysts’ median price.
If we refocus on Virpax Pharmaceuticals Inc (NASDAQ:VRPX), historical trading data shows that trading volumes averaged 0.47 over the past 10 days and 7.23 million over the past 3 months. The company’s latest data on shares outstanding shows there are 26.56 million shares.
The 1.63% of Virpax Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 0.47% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.96 million on 2025-02-28, giving us a short ratio of 0.08. The data shows that as of 2025-02-28 short interest in Virpax Pharmaceuticals Inc (VRPX) stood at 359.99999999999994 of shares outstanding, with shares short rising to 0.63 million registered in 2025-01-31. Current price change has pushed the stock -73.70% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the VRPX stock continues to rise going into the next quarter.
